This article explores the latest conversations around generic topical and transdermal drug delivery systems (TDS) in the US ...

Arvinas announces leadership changes as John Northcott steps down as CCO, with Alex Santini filling the role on an interim ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Lazcluze (lazertinib), in combination with ...

A new study has considered some of the potential benefits and risks of glucagon-like peptide 1 receptor agonists (GLP-1RAs), ...

Circio partners with 4basebio to develop synthetic “circVec” DNA vectors for in vivo gene therapy delivery. The collaboration ...

China’s Junshi Biosciences yesterday revealed that its wholly-owned subsidiary TopAlliance Bioscience has entered into a ...

Dutch biotech Pharming Group today announced that its board of directors has nominated Fabrice Chouraqui to become the ...

Donald Trump formally withdraws the USA from the WHO, citing mismanagement of the COVID-19 pandemic and financial disparities ...

French pharma major Sanofi’s consumer healthcare business, Opella, has announced that the US Food and Drug Administration ...

Patent-filing research conducted by law firm Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising ...

China’s InnoCare Pharma and KeyMed Biosciences and their joint venture have entered into an exclusive license agreement with Prolium Bioscience for the development and commercialization of ICP-B02 ...

BioVersys plans a Q1 2025 IPO on the SIX Swiss Exchange to raise 80 million francs for Phase III trials of BV100 targeting CRAB and Phase II development of alpibectir for TB meningitis. The company ...